Remote Jobs at Immuneering Corporation

Immuneering Corporation

11 - 50 employees

Founded 2008

🧬 Biotechnology

💊 Pharmaceuticals

🔥 Funding within the last year

💰 $200M Post-IPO Equity - Immuneering on 2025-09

Biotechnology • Pharmaceuticals

Immuneering Corporation is a clinical-stage biotechnology company developing a novel class of oncology therapies called Deep Cyclic Inhibitors, which use rhythmic dosing to outpace cancer adaptation, improve tolerability, and extend patient survival and quality of life. The company advances a pipeline through clinical trials, collaborates with partners, and emphasizes scientific research and publications to transform cancer treatment while reducing side effects of traditional continuous-inhibition therapies.